Lucerastat
Product Specifications
CAS Number
141206-42-0
Target
Transferase
Related Pathways
Metabolism
Purity
0.98
Bioactivity
Lucerastat?NBDGJ? is an orally available inhibitor of Glucosylceramide Synthase (GCS) with therapeutic potential for Fabry disease. GCS is a key enzyme in sphingolipid synthesis and inhibition of its activity reduces the accumulation of harmful substrates.
Smiles
C(CCC)N1[C@H](CO)[C@H](O)[C@H](O)[C@@H](O)C1
Molecular Formula
C10H21NO4
Molecular Weight
219.28
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS643899-01 0.1 mg
PI4K2A (Phosphatidylinositol 4-Kinase Type 2-alpha, Phosphatidylinositol 4-kinase Type II-alpha, DKFZp761G1923, PI4KII, PIK42A, RP11-548K23.6)
Ask
View Details MBS643899-02 5x 0.1 mg
PI4K2A (Phosphatidylinositol 4-Kinase Type 2-alpha, Phosphatidylinositol 4-kinase Type II-alpha, DKFZp761G1923, PI4KII, PIK42A, RP11-548K23.6)
Ask
View Details